TB4-Frag vs full TB-500 for tendon stuff, anyone actually compared the two?

Question

Been looking at tb4-frag lately as an alternative to regular tb-500 for a nagging patellar tendon issue thats been hanging around for months. The idea of a shorter fragment with better tissue penetration sounds decent on paper but honestly i cant find much actual comparison data out there. The profile on here /peptides/tb4-fragment says it retains the actin-binding domain so theoretically it should do most of what full tb-4 does for cell migration and angiogenesis. But the dose range is way different, 200-750mcg daily vs 2-5mg twice a week for the full version. That's a massive difference in total peptide per week even at the high end of the fragment range. My question is has anyone here used both and felt a real difference? Like did the fragment actually do anything noticeable for tendon healing or is it just a cheaper marketing angle? I'm a bit sceptical because smaller peptide fragments can sometimes lose activity even if they keep the "key" binding region. Proteins don't always work like lego bricks where you just snap the important bit off and it still functions the same. Also keen to know if anyone ran tb4-frag alongside bpc-157 like a mini wolverine setup. Reckon that could

fasted_scientist · Accepted Answer

Not used tb4-frag myself so can't compare directly, but your scepticism is spot on. The "retain the actin-binding domain so it works the same" argument gets thrown around a lot and it's a massive oversimplification. Full-length thymosin beta-4 has multiple functional domains doing different things, and chopping it down to a fragment can change folding, stability, half-life, all sorts. The binding region being present doesn't mean it behaves identically in vivo. What I'd want to see is any head-to-head in an animal model, even. Last I checked the fragment stuff was mostly theoretical plus some cell culture data, which is a fair way from "this fixes tendons better." The dosing difference you flagged is worth thinking about too. 750mcg daily is about 5mg a week, so the high end isn't actually that far off the low end of full tb-500 protocol. Makes you wonder if the "lower dose" selling point is even real at the upper range. I ran full tb-500 with bpc-157 for a medial elbow thing a while b

kenji_runs · Answer

Honestly that is exactly why i am hesitant. The bit about folding and stability is a fair point and makes the marketing claims look a bit thin. I reckon if the half life is completely different it just complicates the dosing maths too much. Do you know if there are any actual papers comparing the two in animal models or is it all just conjecture at this point? I would rather stick to the full version if the fragment is just a gamble.

labrat_vik · Answer

Yeah, the actin-binding claim feels like a shortcut. I tried tb4-frag 500mcg daily for six weeks on my sore Achilles and saw no change, while tb-500 2.5mg twice weekly gave me noticeable pain drop after three weeks. Makes me wonder about stability.

kenji_runs · Answer

Cheers for that, thats exactly the kind of comparison i was after. Six weeks on the frag with nothing and then tb-500 kicked in at three weeks, thats a pretty clear signal honestly. The stability point is interesting, you reckon the fragment degrades faster once reconstituted or just doesnt survive long enough post-injection to actually reach the tissue?

TB4-Frag vs full TB-500 for tendon stuff, anyone actually compared the two?

Comments